Breaking

WorldUpstart Expands Global Footprint to Bring Healthcare Innovation to the U.S. Market

WorldUpstart proudly announces the launch of its Fall 2025 U.S. Market Gateway Accelerator, featuring a dynamic cohort of international Life Science and MedTech companies. The 8-week hybrid program begins online this week, supporting healthcare startups as they target expansion to the United States. 

This fall’s cohort marks a new milestone for the program, featuring companies from Ecuador, Brazil, and New Zealand for the first time—alongside new participants from familiar innovation hubs like France and South Korea. The program, covering topics like legal, regulatory, reimbursement, operations, and investment, culminates in an immersive four-day U.S. market experience in Philadelphia from October 27–30, featuring an industry showcase, investor pitch sessions, and participation in the region’s largest investment conference, PACT Capital Conference.

This cycle also celebrates the launch of new strategic collaborations with BSRKorea and Innopolis Foundation, two leading innovation ecosystem partners in South Korea. These partnerships further strengthen WorldUpstart’s global sourcing capabilities and deepen its commitment to supporting Korean companies as they scale into the U.S. healthcare market.

“With each cohort, we continue to expand the diversity, global reach, and impact of our accelerator,” said Karina Sotnik, Founder and CEO of WorldUpstart. “We’re especially excited this cycle to welcome our first companies from South America and Oceania, and to deepen our collaboration with Korean innovation leaders to ensure that the most promising companies from around the world get the guidance and connections they need to succeed in the U.S.”

Each company will receive hands-on mentorship, expert advice, and curated introductions to key industry stakeholders across the U.S. throughout the two-month accelerator.

Meet the Fall 2025 Cohort

HuntX Pharma

HuntX Pharma, a deep-tech biopharma company, is developing a new class of small-molecule therapeutics to restore neuronal health in Huntington’s and other neurological diseases caused by axonal transport defects.

CeLLeBRAIN

CELLeBRAIN, Ltd. is a biotech company, based in South Korea, focused on applying the tumor-homing property of MSCs to facilitate more efficient and effective use of gene therapy in treating solid tumors and chronic degenerative diseases.

WittGen Biotechnologies

WittGen leverages its GenAI-empowered LEIBER-X platform for single-cell precision oncology, transforming diverse multi-omics data into high-resolution single-cell insights to uncover intra-tumor heterogeneity, discover novel cancer subtypes, accelerate successful drug development, and enable personalized cancer treatment.

BeNatureBioLab

BeNatureBioLab (BNBL) develops proprietary HME-DDS™ formulation technology and provides CDMO services to create higher-absorption oral and transdermal dosage forms, offering end-to-end support from formulation through scale-up and regulatory readiness.

Connext Health

Connext Health is an AI-powered analytics platform that connects pharma R&D, investors, and startups by delivering curated scouting, partner briefs, and translational insights to accelerate innovation in areas like AI, genomics, and digital therapeutics.

Quantum Medical

Quantum Medical enables innovative solutions for chronic kidney disease, including its Hemodiafiltration Conversion System designed to make hemodialysis more effective, efficient, and accessible for underserved patients worldwide.

Fur Love

Fur Love is a veterinary-recommended pet care brand, offering science-backed, human-grade skincare solutions for dogs, with clinically validated products that address common dermatological issues like dryness, itchiness, and tangles.

About WorldUpstart

WorldUpstart empowers international life sciences, MedTech, and digital health companies to successfully enter and grow in the U.S. market. Its U.S. Market Gateway Accelerator, recognized among the Top 10 Accelerators by both Hattrick IT and Startup Savant, provides the strategic guidance, mentorship, and networks needed for global startups to thrive in the competitive U.S. healthcare landscape. Visit www.worldupstart.com to learn more.

Joseph Wilson

Joseph Wilson is a veteran journalist with a keen interest in covering the dynamic worlds of technology, business, and entrepreneurship.

Recent Posts

Industry veteran Jan Chen joins Anja Health as CEO, bringing 18 years of stem cell banking leadership and family-focused expertise

LOS ANGELES, CA, UNITED STATES -- Anja Health, a leading provider of cord blood, cord…

1 day ago

BEEKEEPER’S NATURALS ANNOUNCES FIRST CHILDREN’S BOOK BY FOUNDER CARLY KREMER: LITTLE BEE AND THE BLOOM

LOS ANGELES, CA – Beekeepers' Naturals is pleased to announce the first children’s book from…

1 day ago

Trade Compliance Records Publishes Reference Library on PVoC, CBAM, and DPP

Trade Compliance Records has published a primary-source reference library covering South Africa's 20 September 2026…

1 day ago

SecurityHQ Appoints Aaron Hambleton as Senior Vice President of Product & Services

The newly formalized role reflects SecurityHQ’s push to turn security operations from reactive monitoring into…

1 day ago

Xenix Medical Announces FDA Clearance and Full Commercial Launch of the Riva Posterior Fixation System®

Modular Design and Versatile Tulip Head and Screw Shank Options Address Complex Spinal Anatomy and…

1 day ago

GCL’s 4Divinity Enters into MOU with Chengdu Cangmo for Global Publishing Rights of Wuxia Action-RPG ‘A Whisper of Fall:Jinyiwei’

SINGAPORE — GCL Global Holdings Ltd (Nasdaq: GCL) (GCL” or the “Company”), a leading provider…

1 day ago

This website uses cookies.